New clip could make robotic cancer surgery safer
NCT ID NCT07413120
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new surgical clip called VasoClip, designed to hold blood vessels closed more securely during robotic surgery for prostate, kidney, or bladder cancer. Forty patients were randomly assigned to receive either the new clip or a standard clip. The goal was to see if the new clip prevents slipping and works as well or better than the current option.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- VasoClip implantable vascular clip (device)
- What this could lead to
- If successful, this clip could reduce surgical complications like bleeding or clip slippage during robotic prostate or kidney cancer surgery.
- What could go wrong
- This is a small, early-phase trial with only 40 patients. The clip may not perform better than existing clips, and device-related risks like tissue damage or clip failure remain possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
40 people
The number who actually took part.
- Started
-
May 2020
- Finished
-
Dec 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 20 years or older. * Scheduled for robotic or laparoscopic urologic surgery where the use of polymer ligating clips is anticipated. * Voluntary informed consent. Exclusion Criteria: * Clinically significant coagulation disorders (PT-INR \> 1.2). * Severe vascular diseases (e.g., peripheral arterial occlusion, microvascular heart disease). * Comorbidities inducing excessive bleeding (e.g., active urinary tract infection, liver cirrhosis). * Conditions affecting blood cell or platelet production (e.g., leukemia). * Known coagulation factor deficiencies (e.g., hemophilia)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney cancers are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Catholic University of Korea, Incheon St. Mary's Hospital
Incheon, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Brain-Tumor dye light up kidney cancer during surgery?
- Can a radioactive tracer and MRI reveal prostate Cancer's true extent?
- Can a One-Two radiation punch improve prostate cancer control?
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers
- Can a special PET scan change the course of prostate cancer?
- Lab-Grown tumor models could match patients to the right cancer drug